On Nov. 19, 2020, Medigen Vaccine Biologics announced that preclinical results of their COVID-19 vaccine candidate had been peer-reviewed and published in Scientific Reports, the internationally renowned SCI journal of the Nature Publishing Group. The published manuscript was previously available as pre-print on bioRxiv.org.